 | Up a level |
Kremenovic, Mirela; Chan, Alfred A; Feng, Bing; Bäriswyl, Lukas; Robatel, Steve; Gruber, Thomas; Tang, Li; Lee, Delphine J; Schenk, Mirjam (2022). BCG hydrogel promotes CTSS-mediated antigen processing and presentation, thereby suppressing metastasis and prolonging survival in melanoma. Journal for immunotherapy of cancer, 10(6), e004133. BioMed Central 10.1136/jitc-2021-004133
Gruber, Thomas; Robatel, Steve; Kremenovic, Mirela; Bäriswyl, Lukas; Gertsch, Jürg; Schenk, Mirjam (2021). Cannabinoid Receptor Type-2 in B Cells Is Associated with Tumor Immunity in Melanoma. Cancers, 13(8) MDPI AG 10.3390/cancers13081934
Kremenovic, M.; Schenk, Mirjam; Lee, D. J. (2020). Clinical and molecular insights into BCG immunotherapy for melanoma. Journal of internal medicine, 288(6), pp. 625-640. Wiley 10.1111/joim.13037
Gruber, Thomas; Kremenovic, Mirela; Sadozai, Hassan; Rombini, Nives; Baeriswyl, Lukas; Maibach, Fabienne; Modlin, Robert L; Gilliet, Michel; von Werdt, Diego; Hunger, Robert E.; Jafari, S. Morteza Seyed; Parisi, Giulia; Abril-Rodriguez, Gabriel; Ribas, Antoni; Schenk, Mirjam (2020). IL-32γ potentiates tumor immunity in melanoma. JCI insight, 5(18) JCI Insight 10.1172/jci.insight.138772
Kremenovic, Mirela; Rombini, Nives; Chan, Alfred A.; Gruber, Thomas; Bäriswyl, Lukas; Lee, Delphine J.; Schenk, Mirjam (2020). Characterization of a Myeloid Activation Signature that Correlates with Survival in Melanoma Patients. Cancers, 12(6), p. 1431. MDPI AG 10.3390/cancers12061431
